Whartenby KA - Search Results

1

Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells.

Goldberg MV, Maris CH, Hipkiss EL, Flies AS, Zhen L, Tuder RM, Grosso JF, Harris TJ, Getnet D, Whartenby KA, Brockstedt DG, Dubensky TW Jr, Chen L, Pardoll DM, Drake CG. Goldberg MV, et al. Among authors: whartenby ka. Blood. 2007 Jul 1;110(1):186-92. doi: 10.1182/blood-2006-12-062422. Epub 2007 Mar 28. Blood. 2007. PMID: 17392506 Free PMC article.

2

Transduction of donor hematopoietic stem-progenitor cells with Fas ligand enhanced short-term engraftment in a murine model of allogeneic bone marrow transplantation.

Whartenby KA, Straley EE, Kim H, Racke F, Tanavde V, Gorski KS, Cheng L, Pardoll DM, Civin CI. Whartenby KA, et al. Blood. 2002 Nov 1;100(9):3147-54. doi: 10.1182/blood-2002-01-0118. Blood. 2002. PMID: 12384412 Free article.

3

Inhibition of activation-induced death of dendritic cells and enhancement of vaccine efficacy via blockade of MINOR.

Wang T, Jiang Q, Chan C, Gorski KS, McCadden E, Kardian D, Pardoll D, Whartenby KA. Wang T, et al. Among authors: whartenby ka. Blood. 2009 Mar 26;113(13):2906-13. doi: 10.1182/blood-2008-08-176354. Epub 2009 Jan 22. Blood. 2009. PMID: 19164597 Free PMC article.

4

Feedback inhibition of calcineurin and Ras by a dual inhibitory protein Carabin.

Pan F, Sun L, Kardian DB, Whartenby KA, Pardoll DM, Liu JO. Pan F, et al. Among authors: whartenby ka. Nature. 2007 Jan 25;445(7126):433-6. doi: 10.1038/nature05476. Epub 2007 Jan 17. Nature. 2007. PMID: 17230191

5

Immunotherapy of established tumors using bone marrow transplantation with antigen gene--modified hematopoietic stem cells.

Cui Y, Kelleher E, Straley E, Fuchs E, Gorski K, Levitsky H, Borrello I, Civin CI, Schoenberger SP, Cheng L, Pardoll DM, Whartenby KA. Cui Y, et al. Among authors: whartenby ka. Nat Med. 2003 Jul;9(7):952-8. doi: 10.1038/nm882. Nat Med. 2003. PMID: 12778137

6

Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease.

Whartenby KA, Calabresi PA, McCadden E, Nguyen B, Kardian D, Wang T, Mosse C, Pardoll DM, Small D. Whartenby KA, et al. Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16741-6. doi: 10.1073/pnas.0506088102. Epub 2005 Nov 4. Proc Natl Acad Sci U S A. 2005. PMID: 16272221 Free PMC article.

7

Blockade of Kv1.3 potassium channels inhibits differentiation and granzyme B secretion of human CD8+ T effector memory lymphocytes.

Hu L, Wang T, Gocke AR, Nath A, Zhang H, Margolick JB, Whartenby KA, Calabresi PA. Hu L, et al. Among authors: whartenby ka. PLoS One. 2013;8(1):e54267. doi: 10.1371/journal.pone.0054267. Epub 2013 Jan 30. PLoS One. 2013. PMID: 23382885 Free PMC article.

8

Human CD34+ hematopoietic stem/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis.

Kim H, Whartenby KA, Georgantas RW 3rd, Wingard J, Civin CI. Kim H, et al. Among authors: whartenby ka. Stem Cells. 2002;20(2):174-82. doi: 10.1634/stemcells.20-2-174. Stem Cells. 2002. PMID: 11897874

9

Mesenchymal stem cells differentially modulate effector CD8+ T cell subsets and exacerbate experimental autoimmune encephalomyelitis.

Glenn JD, Smith MD, Calabresi PA, Whartenby KA. Glenn JD, et al. Among authors: whartenby ka. Stem Cells. 2014 Oct;32(10):2744-55. doi: 10.1002/stem.1755. Stem Cells. 2014. PMID: 24911892 Free PMC article.

10

Kinetics of CCR7 expression differ between primary activation and effector memory states of T(H)1 and T(H)2 cells.

Calabresi PA, Allie R, Mullen KM, Yun SH, Georgantas RW 3rd, Whartenby KA. Calabresi PA, et al. Among authors: whartenby ka. J Neuroimmunol. 2003 Jun;139(1-2):58-65. doi: 10.1016/s0165-5728(03)00127-9. J Neuroimmunol. 2003. PMID: 12799021

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page